We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Case report demonstrates treatment with ravulizumab in catastrophic antiphospholipid syndrome with aortitis, highlighting complement inhibition as a viable therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Ferhadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: